Longbang Chen

11.1k total citations · 1 hit paper
155 papers, 8.1k citations indexed

About

Longbang Chen is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Longbang Chen has authored 155 papers receiving a total of 8.1k indexed citations (citations by other indexed papers that have themselves been cited), including 118 papers in Molecular Biology, 71 papers in Cancer Research and 42 papers in Oncology. Recurrent topics in Longbang Chen's work include MicroRNA in disease regulation (42 papers), Cancer-related molecular mechanisms research (42 papers) and RNA modifications and cancer (37 papers). Longbang Chen is often cited by papers focused on MicroRNA in disease regulation (42 papers), Cancer-related molecular mechanisms research (42 papers) and RNA modifications and cancer (37 papers). Longbang Chen collaborates with scholars based in China and United States. Longbang Chen's co-authors include Yitian Chen, Changqian Wang, Yang Xiang, Haizhu Song, Guichun Huang, Bing Feng, Rui Wang, Rui Wang, Xiaoyuan Chu and Yitian Chen and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Longbang Chen

154 papers receiving 8.0k citations

Hit Papers

The Versatile Role of mic... 2017 2026 2020 2023 2017 500 1000 1.5k

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Longbang Chen 5.9k 4.7k 1.7k 771 597 155 8.1k
Hu‐Liang Jia 4.6k 0.8× 3.6k 0.8× 2.0k 1.2× 661 0.9× 731 1.2× 92 7.5k
Yunfei Yuan 4.8k 0.8× 3.7k 0.8× 1.7k 1.0× 837 1.1× 1.1k 1.8× 187 8.2k
Andreas G. Bader 7.2k 1.2× 5.3k 1.1× 1.6k 0.9× 792 1.0× 236 0.4× 58 8.9k
Amaia Lujambio 4.2k 0.7× 2.8k 0.6× 1.2k 0.7× 631 0.8× 445 0.7× 54 6.1k
Hirotaka Osada 6.5k 1.1× 4.2k 0.9× 1.7k 1.0× 1.4k 1.8× 357 0.6× 73 8.5k
M. James You 4.5k 0.8× 2.5k 0.5× 2.1k 1.3× 1.1k 1.4× 337 0.6× 129 7.3k
Erinn B. Rankin 3.4k 0.6× 3.1k 0.7× 1.5k 0.9× 1.0k 1.3× 359 0.6× 71 7.0k
Ai‐Wu Ke 3.7k 0.6× 2.2k 0.5× 1.4k 0.8× 624 0.8× 1.1k 1.8× 93 5.9k
Muh‐Hwa Yang 4.0k 0.7× 2.2k 0.5× 2.9k 1.7× 990 1.3× 606 1.0× 164 7.6k
David J. Wong 5.7k 1.0× 4.3k 0.9× 1.1k 0.6× 391 0.5× 434 0.7× 28 7.7k

Countries citing papers authored by Longbang Chen

Since Specialization
Citations

This map shows the geographic impact of Longbang Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Longbang Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Longbang Chen more than expected).

Fields of papers citing papers by Longbang Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Longbang Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Longbang Chen. The network helps show where Longbang Chen may publish in the future.

Co-authorship network of co-authors of Longbang Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Longbang Chen. A scholar is included among the top collaborators of Longbang Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Longbang Chen. Longbang Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jiang, Min, Kai Zhang, Qi Feng, et al.. (2025). HDAC4 super-enhancer drives CEBPB-mediated TWIST2 transcription to promote chemoresistance in LUAD. Cancer Letters. 623. 217716–217716. 1 indexed citations
2.
Wang, Changqian, Yang Xiang, Yitian Chen, & Longbang Chen. (2017). The Versatile Role of microRNA-30a in Human Cancer. Cellular Physiology and Biochemistry. 41(4). 1616–1632. 1947 indexed citations breakdown →
3.
Xie, Tao, Jian Geng, Ye Wang, et al.. (2016). FOXM1 evokes 5-fluorouracil resistance in colorectal cancer depending on ABCC10. Oncotarget. 8(5). 8574–8589. 59 indexed citations
4.
Tao, Leilei, Guichun Huang, Yitian Chen, & Longbang Chen. (2015). DNA Methylation of DKK3 Modulates Docetaxel Chemoresistance in Human Nonsmall Cell Lung Cancer Cell. Cancer Biotherapy and Radiopharmaceuticals. 30(2). 100–106. 22 indexed citations
5.
Chen, Longbang. (2013). Expression of MTA1 protein in non-small cell lung cancer and its association with the prognosis of the disease. Yixue yanjiusheng xuebao. 1 indexed citations
6.
Ren, Jin, Rui Wang, Guichun Huang, et al.. (2013). sFRP1 Inhibits Epithelial–Mesenchymal Transition in A549 Human Lung Adenocarcinoma Cell Line. Cancer Biotherapy and Radiopharmaceuticals. 28(7). 565–571. 28 indexed citations
7.
Chen, Jing, Xiang Huang, Guichun Huang, et al.. (2012). Preconditioning Chemotherapy with Cisplatin Enhances the Antitumor Activity of Cytokine-Induced Killer Cells in a Murine Melanoma Model. Cancer Biotherapy and Radiopharmaceuticals. 27(3). 210–220. 40 indexed citations
8.
Huang, Guichun, Jian Geng, Rui Wang, & Longbang Chen. (2012). Identification of a New Cytotoxic T-Cell Epitope p675 of Human Telomerase Reverse Transcriptase. Cancer Biotherapy and Radiopharmaceuticals. 27(9). 600–605. 3 indexed citations
9.
He, Weiwei, Xueting Wang, Longbang Chen, & Xiaoxiang Guan. (2012). A Crosstalk Imbalance Between p27 Kip1 and Its Interacting Molecules Enhances Breast Carcinogenesis. Cancer Biotherapy and Radiopharmaceuticals. 27(7). 399–402. 25 indexed citations
10.
Tang, Lin, et al.. (2012). p27 Kip1 V109G Polymorphism and Cancer Risk: A Systematic Review and Meta-Analysis. Cancer Biotherapy and Radiopharmaceuticals. 27(10). 665–671. 19 indexed citations
11.
Song, Haizhu, Jun Yi, Youwei Zhang, Rui Wang, & Longbang Chen. (2011). [DNA methylation of tumor suppressor genes located on chromosome 3p in non-small cell lung cancer].. Europe PMC (PubMed Central). 14(3). 233–8. 12 indexed citations
12.
Chen, Longbang. (2010). Analysis of RUNX3 promoter hypermethylation in the serum DNA of gastric and colorectal adenocarcinoma patients. Yixue yanjiusheng xuebao. 2 indexed citations
13.
Chen, Longbang, et al.. (2010). Methylation status of DLEC1 promoter in colorectal cancer patients and its clinical relevance. Academic Journal of Second Military Medical University. 2 indexed citations
14.
Feng, Bing & Longbang Chen. (2009). Review of Mesenchymal Stem Cells and Tumors: Executioner or Coconspirator?. Cancer Biotherapy and Radiopharmaceuticals. 24(6). 717–721. 66 indexed citations
15.
Huang, Guichun & Longbang Chen. (2009). Discrepancies Between Antiangiogenic and Antitumor Effects of Recombinant Human Endostatin. Cancer Biotherapy and Radiopharmaceuticals. 24(5). 589–596. 8 indexed citations
16.
Chen, Longbang, et al.. (2009). The Antitumor Effects of CIK Cells Combined with Docetaxel Against Drug-Resistant Lung Adenocarcinoma Cell Line SPC-A1/DTX in Vitro and in Vivo. Cancer Biotherapy and Radiopharmaceuticals. 24(1). 91–98. 25 indexed citations
17.
Huang, Guichun & Longbang Chen. (2008). Review : Tumor Vasculature and Microenvironment Normalization: A Possible Mechanism of Antiangiogenesis Therapy. Cancer Biotherapy and Radiopharmaceuticals. 23(5). 661–668. 23 indexed citations
18.
Chen, Longbang. (2007). Role of histone acetylation modification in posttranscriptional gene expression. Zhonghua zhongliu fangzhi zazhi. 1 indexed citations
19.
Chen, Longbang. (2007). Establishment and characterization of a docetaxel-resistant variant of human lung adenocarcinoma cell line SPC-A1. Zhongguo aizheng zazhi. 1 indexed citations
20.
Chen, Longbang. (2006). Analysis of Promoter Hypermethylation of p16 Gene and DAPK Gene in Sera from Primary Liver Cancer Patients. Zhongliu fangzhi yanjiu. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026